CM
GILD icon

Churchill Management’s Gilead Sciences GILD Stock Holding History

Churchill Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$18.1M Buy
163,496
+120,165
+277% +$12.8M 0.2% 42
2025
Q1 		$4.86M Buy
+43,331
New +$4.47M 0.06% 97
2022
Q1 		– Sell
-125,256
Closed -$9.1M – 128
2021
Q4 		$9.1M Sell
125,256
-4,255
-3% -$293K 0.13% 87
2021
Q3 		$9.05M Buy
+129,511
New +$9.1M 0.14% 83
2020
Q3 		– Sell
-197,024
Closed -$15.2M – 122
2020
Q2 		$15.2M Sell
197,024
-10,952
-5% -$839K 0.47% 29
2020
Q1 		$15.5M Buy
+207,976
New +$14.4M 0.78% 18
2014
Q4 		– Sell
-20,025
Closed -$2.13M – 188
2014
Q3 		$2.13M Buy
20,025
+15,214
+316% +$1.49M 0.09% 113
2014
Q2 		$399K Sell
4,811
-1,850,087
-100% -$144M 0.02% 156
2014
Q1 		$131M Buy
1,854,898
+548,854
+42% +$43M 5.16% 5
2013
Q4 		$98.1M Buy
1,306,044
+1,277,900
+4,541% +$89M 3.76% 9
2013
Q3 		$1.77M Sell
28,144
-1,245
-4% -$74.4K 0.09% 72
2013
Q2 		$1.51M Buy
+29,389
New +$1.53M 0.07% 72

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Churchill Management's GILD Position: Q2 2025 in Review

Churchill Management increased its Gilead Sciences (GILD) stake by 277% in Q2 2025, buying an estimated $12.8M and bringing the position to 163,496 shares worth $18.1M. The position accounts for 0.2% of the portfolio, ranked #42.

Churchill Management first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $131M in Q1 2014. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Churchill Management held 163,496 shares of Gilead Sciences worth $18.1M as of Q2 2025.
  • Churchill Management bought 120,165 Gilead Sciences shares in Q2 2025, an estimated $12.8M.
  • Gilead Sciences made up 0.2% of Churchill Management's portfolio in Q2 2025, its #42 holding.
  • Churchill Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
  • Churchill Management's Gilead Sciences position peaked at $131M in Q1 2014.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Churchill Management's 13F filing for Q2 2025, filed 18 Jul 2025.